Skip to content
Snippets Groups Projects
Commit fe5ec18c authored by VIKAS SHARMA's avatar VIKAS SHARMA
Browse files

Update

parents
No related branches found
No related tags found
No related merge requests found
Showing
with 69 additions and 0 deletions
#create directory
mkdir 2023_Krueger_prophage_lysis-lysogeny_MrpR
#go to created directory
cd 2023_Krueger_prophage_lysis-lysogeny_MrpR/
#Initialize your ARC by executing
arc init
##Adding metadata
#ISA investigation
arc investigation create -i 2023_Krueger_prophage_lysis-lysogeny_MrpR
#ISA studies
#arc study add -s 2023_Krueger_prophage_lysis-lysogeny_MrpR
#ISA studies & assays
arc assay add -s 2022_Krüger_pseudokinase_heme_tolerance -a ChAPSeq-Illumina
####Sharing your ARC
#Allow git to store credentials on your machine.
git config --global credential.helper store
#created token manually
Create and set an access token
arc sync -f -r https://git.nfdi4plants.org/v.sharma/2023_Krueger_prophage_lysis-lysogeny_MrpR -m "initialize ARC structure"
#create directory
mkdir 2023_Krueger_prophage_lysis-lysogeny_MrpR
#go to created directory
cd 2023_Krueger_prophage_lysis-lysogeny_MrpR/
#Initialize your ARC by executing
arc init
##Adding metadata
#ISA investigation
arc investigation create -i 2023_Krueger_prophage_lysis-lysogeny_MrpR
#ISA studies
#arc study add -s 2023_Krueger_prophage_lysis-lysogeny_MrpR
#ISA studies & assays
arc assay add -s 2022_Krüger_pseudokinase_heme_tolerance -a ChAPSeq-Illumina
#ISA studies & assays
arc assay add -s 2022_Krüger_pseudokinase_heme_tolerance -a BioLector
####Sharing your ARC
#Allow git to store credentials on your machine.
git config --global credential.helper store
#created token manually
Create and set an access token
arc sync -f -r https://git.nfdi4plants.org/v.sharma/2023_Krueger_prophage_lysis-lysogeny_MrpR -m "initialize ARC structure"
,sharma,ibt045.ibt.kfa-juelich.de,12.12.2023 16:36,file:///home/IBT/sharma/.config/libreoffice/4;
\ No newline at end of file
File added
File added
File added
0% Loading or .
You are about to add 0 people to the discussion. Proceed with caution.
Finish editing this message first!
Please register or to comment